H1N1 Vaccines Market By Vaccine Type (Live Attenuated Vaccine and Inactivated Vaccine), Route Of Administration (Intranasal Vaccine and Injectable Vaccine) and Distribution Channel (Online Pharmacy, Hospital Pharmacy and Retail Pharmacy) - Global Industry Analysis And Forecast To 2025

Industry Outlook

H1N1 is also referred to as Swine Flu, as the people who suffered from it where in direct contact with the pigs. The scenario changed after period of time when people started to get affected by the disease without being in contact with pigs. H1N1 was spreading fast in the year 2009, WHO termed it as a pandemic. Symptoms of H1N1 are similar to that of common flu that include; fever, cough, chills, fatigue, headaches, sore throat, etc. H1N1 can have widespread effect if not treated like; lung infection, pneumonia, breathing problems, etc. H1N1 Vaccines use is growing owing to factors like; increasing number of aged population, rising number of cases of the disease, increase in the initiatives by the government across the globe, seasonal occurrence seen in the H1N1 disease, etc. Therefore, the H1N1 Vaccines Market is anticipated to expand and has tremendous scope during the forecast period. The global H1N1 Vaccines Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

The global H1N1 Vaccines Market is based on segment, by Vaccine Type the market is segmented into Live Attenuated Vaccine and Inactivated Vaccine, by Route Of Administration the market is segmented into Intranasal Vaccine and Injectable Vaccine, and by Distribution Channel the market is segmented into Online Pharmacy, Hospital Pharmacy and Retail Pharmacy.

H1N1 Vaccines Market, By Vaccine Type

Live Attenuated Vaccine
Inactivated Vaccine

H1N1 Vaccines Market, By Route Of Administration

Intranasal Vaccine
Injectable Vaccine

H1N1 Vaccines Market, By Distribution Channel

Online Pharmacy
Hospital Pharmacy
Retail Pharmacy

Regional Insights

On a global front, the H1N1 Vaccines Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA).

H1N1 Vaccines Market, By Region

North America



Rest of Europe


South Korea
Southeast Asia
Rest of Asia-Pacific

South America

Rest of South America

Middle East and Africa

Saudi Arabia
South Africa
Rest of MEA

Competitive Analysis

The leading players in the market are Abbott Healthcare, CSL Biotherapeutics, ID Biomedical Corporation, Medimmune, Lupin Ltd., AstraZeneca, Sinovac, Cadila Healthcare, GlaxoSmithKline, Sanofi Pasture, Novartis and Serum Institute of India. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

Abbott Healthcare
CSL Biotherapeutics
ID Biomedical Corporation
Lupin Ltd.
Cadila Healthcare
Sanofi Pasture
Serum Institute of India

Some of the key questions answered by the report are:

What was the market size in 2014 and forecast from 2015 to 2025?
What will be the industry market growth from 2015 to 2025?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?